AMC
AMC Entertainment Holdings, Inc.
AMC lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
NAMI
Jinxin Technology Holding Company American Depositary Shares
There isn't enough reported data to score NAMI yet.
AMC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Under pressure |
AMC's revenue is currently healthy, and its profitability and cash flow are stable, but its balance sheet is under pressure.
NAMI Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
NAMI's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
AMC PE Valuation
AMC has no meaningful PE right now: it lost money over the past year.
NAMI PE Valuation
NAMI has no meaningful PE right now: it lost money over the past year.
AMC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect AMC's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
NAMI Forward outlook
There aren't enough analyst estimates for NAMI to show an outlook.
AMC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.40 | +$0.94 |
| Q2 2026 | -$1.10 | -$0.28 |
| Q1 2026 | -$1.09 | -$0.18 |
| Q4 2025 | -$1.34 | -$0.28 |
| Q3 2025 | -$1.34 | +$0.29 |
| Q2 2025 | -$0.82 | +$0.67 |
| Q1 2025 | -$0.91 | +$0.38 |
| Q4 2024 | -$1.06 | +$1.31 |
AMC lost $0.40 per share over the past year, a smaller loss than the year before.
NAMI Earnings Per Share
NAMI and AMC do not have enough comparable growth data to identify a winner.
AMC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | +32% |
| Q2 2026 | $1.6B | +14% |
| Q1 2026 | $1B | +21% |
| Q4 2025 | $1.3B | -1.4% |
| Q3 2025 | $1.3B | -3.6% |
| Q2 2025 | $1.4B | +36% |
| Q1 2025 | $862.5M | -9.3% |
| Q4 2024 | $1.3B | +18% |
AMC has the edge over NAMI in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +12 points |
| Q2 2026 | 15% | +8.3 points |
| Q1 2026 | -4.4% | +13 points |
| Q4 2025 | 0% | -0.3 points |
| Q3 2025 | 2.8% | -2.6 points |
| Q2 2025 | 6.6% | +11 points |
| Q1 2025 | -17% | -5.5 points |
| Q4 2024 | 0.4% | +14 points |
AMC has the edge over NAMI on profitability, with a higher operating margin.
NAMI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $21.4M | -32% |
| Q4 2025 | $30.7M | -1.9% |
| Q2 2025 | $31.3M | +5.3% |
| Q4 2024 | $31.3M | -0.7% |
| Q2 2024 | $29.7M | +17% |
AMC has the edge over NAMI in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -10% | -26 points |
| Q4 2025 | -39% | -60 points |
| Q2 2025 | -11% | -33 points |
| Q4 2024 | -2.3% | N/A |
| Q2 2024 | 16% | N/A |
| Q4 2023 | 21% | N/A |
| Q2 2023 | 22% | N/A |
NAMI's operating margin was −10% last quarter, down 26 points from the same quarter a year ago.
AMC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $109.3M | +$190.4M |
| Q2 2026 | $190.1M | +114% |
| Q1 2026 | -$174.7M | +$242.3M |
| Q4 2025 | $43.3M | -62% |
| Q3 2025 | -$81.1M | +$11.1M |
| Q2 2025 | $88.9M | +$168.1M |
| Q1 2025 | -$417M | -$178.2M |
| Q4 2024 | $113.9M | +$263.8M |
AMC's free cash flow has turned positive after six years mostly in the red: $168M over the past year.
NAMI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$413.5K | -137% |
| Q4 2025 | -$4.9M | -810% |
| Q2 2025 | $1.1M | -63% |
| Q4 2024 | $693K | -76% |
| Q2 2024 | $3M | -46% |
NAMI and AMC do not have enough comparable growth data to identify a winner.
AMC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +24% | +175M shares |
| 1 year | +107% | +463M shares |
| 3 years | +767% | +793M shares |
| 5 years | +4063% | +875M shares |
AMC has 897M diluted shares, up 107% from a year ago.
NAMI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.1% | +2M shares |
| 1 year | +93% | +24.2M shares |
NAMI has the edge over AMC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $7,524 |
| Q4 2024 | — |
| Q2 2024 | — |
| Q4 2023 | — |
| Q2 2023 | — |
AMC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 9.2x | High |
| Q4 2025 | 12.2x | High |
| Q3 2025 | 12.2x | High |
| Q2 2025 | 10.7x | High |
| Q1 2025 | 18.6x | High |
| Q4 2024 | 14.3x | High |
AMC's net debt is about 4.0 years of its operating earnings (EBITDA), down from 12 years a year ago.
NAMI Net Leverage
NAMI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AMC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.3 | Neutral |
| Stochastic | 65.4 | Neutral |
AMC's weekly RSI is 67 (neutral) and its Stochastic is 65 (neutral).
NAMI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.0 | Neutral |
| Stochastic | 3.9 | Oversold |
NAMI's weekly RSI is 31 (neutral) and its Stochastic is 4 (oversold).
AMC PE vs Communication Services Sector
AMC has no meaningful PE right now: it lost money over the past year.
NAMI PE vs Communication Services Sector
NAMI has no meaningful PE right now: it lost money over the past year.
AMC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.01 | 11% above |
| 20 week MA | $2.64 | 27% above |
| 50 week MA | $2.01 | 66% above |
| 100 week MA | $2.53 | 32% above |
| 200 week MA | $10.9 | 69% below |
AMC has stronger trend alignment. AMC is above 4 of 5 weekly averages versus NAMI above 0 of 4.
NAMI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.86 | 13% below |
| 20 week MA | $2.50 | 35% below |
| 50 week MA | $8.83 | 82% below |
| 100 week MA | $30.2 | 95% below |
NAMI is in a downtrend: it's below all four of its weekly moving averages, and 95% below its 100-week average.
AMC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.5 | $12.6 | -66% |
| 2021 | $12.6 | $142.6 | +1036% |
| 2022 | $142.6 | $44.0 | -69% |
| 2023 | $44.0 | $6.12 | -86% |
| 2024 | $6.12 | $4.00 | -35% |
| 2025 | $4.00 | $1.69 | -58% |
| 2026 YTD | $1.69 | $3.34 | +98% |
AMC has the edge over NAMI on returns for 2026, with the stronger performance.
NAMI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $111.0 | $104.5 | -5.9% |
| 2025 | $104.5 | $18.4 | -82% |
| 2026 YTD | $18.4 | $1.62 | -91% |
NAMI has finished every year since 2024 lower, and it's down 91% so far in 2026.